Trending Stock News

Disciplined Growth Investors Increases Holding in Cognex Com (CGNX); Agios Pharmaceuticals (AGIO) Shareholder Pdt Partners Has Decreased Its Position by $1.99 Million as Stock Rose

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Logo

Peter Muller decreased its stake in Agios Pharmaceuticals Inc (AGIO) by 18.72% based on its latest 2017Q4 regulatory filing with the SEC. Pdt Partners Llc sold 34,833 shares as the company’s stock rose 38.11% while stock markets declined. The hedge fund run by Peter Muller held 151,268 shares of the health care company at the end of 2017Q4, valued at $8.65 million, down from 186,101 at the end of the previous reported quarter. Pdt Partners Llc who had been investing in Agios Pharmaceuticals Inc for a number of months, seems to be less bullish one the $5.14 billion market cap company. The stock increased 3.83% or $3.29 during the last trading session, reaching $89.23. About 433,481 shares traded or 18.46% up from the average. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has risen 41.40% since May 23, 2017 and is uptrending. It has outperformed by 29.85% the S&P500.

Disciplined Growth Investors Inc increased its stake in Cognex Corp Com (CGNX) by 97.76% based on its latest 2017Q4 regulatory filing with the SEC. Disciplined Growth Investors Inc bought 414,079 shares as the company’s stock declined 13.83% with the market. The institutional investor held 837,649 shares of the industrial machinery and components company at the end of 2017Q4, valued at $51.23 million, up from 423,570 at the end of the previous reported quarter. Disciplined Growth Investors Inc who had been investing in Cognex Corp Com for a number of months, seems to be bullish on the $7.99 billion market cap company. The stock decreased 0.28% or $0.13 during the last trading session, reaching $46.21. About 405,373 shares traded. Cognex Corporation (NASDAQ:CGNX) has risen 31.99% since May 23, 2017 and is uptrending. It has outperformed by 20.44% the S&P500.

Since March 12, 2018, it had 0 buys, and 1 insider sale for $564,892 activity.

More news for Cognex Corporation (NASDAQ:CGNX) were recently published by: Seekingalpha.com, which released: “Will Cognex Stock Keep Falling?” on May 09, 2018. Streetinsider.com‘s article titled: “Pre-Open Movers 05/01: (INGN) (KPTI) (NTRI) Higher; (IVAC) (CGNX) (KLXI) Lower (more…)” and published on May 01, 2018 is yet another important article.

Disciplined Growth Investors Inc, which manages about $4.06 billion and $5.07B US Long portfolio, decreased its stake in Intuit Com (NASDAQ:INTU) by 9,404 shares to 1.27 million shares, valued at $199.86M in 2017Q4, according to the filing. It also reduced its holding in Plantronics Inc New Com (NYSE:PLT) by 8,662 shares in the quarter, leaving it with 1.91M shares, and cut its stake in Under Armour Inc Cl A (NYSE:UA).

Among 19 analysts covering Cognex Corporation (NASDAQ:CGNX), 9 have Buy rating, 3 Sell and 7 Hold. Therefore 47% are positive. Cognex Corporation had 47 analyst reports since August 4, 2015 according to SRatingsIntel. Canaccord Genuity downgraded Cognex Corporation (NASDAQ:CGNX) on Tuesday, August 4 to “Hold” rating. On Wednesday, April 4 the stock rating was upgraded by Northcoast to “Buy”. Canaccord Genuity maintained Cognex Corporation (NASDAQ:CGNX) rating on Thursday, February 15. Canaccord Genuity has “Hold” rating and $57.0 target. Raymond James initiated Cognex Corporation (NASDAQ:CGNX) on Friday, January 22 with “Outperform” rating. JP Morgan downgraded the shares of CGNX in report on Monday, May 7 to “Underweight” rating. The company was maintained on Tuesday, May 1 by JP Morgan. The rating was downgraded by CLSA on Tuesday, November 3 to “Outperform”. As per Wednesday, November 18, the company rating was upgraded by Canaccord Genuity. The firm has “Neutral” rating given on Tuesday, May 1 by Robert W. Baird. The stock has “Underperform” rating by CSLA on Thursday, March 24.

Investors sentiment increased to 6.53 in Q4 2017. Its up 5.48, from 1.05 in 2017Q3. It is positive, as 32 investors sold CGNX shares while 21 reduced holdings. 84 funds opened positions while 262 raised stakes. 268.44 million shares or 268.52% more from 72.84 million shares in 2017Q3 were reported. Congress Asset Mngmt Ma has 1.67M shares. British Columbia Investment Corporation holds 0.06% or 146,755 shares in its portfolio. Fifth Third Financial Bank holds 0% of its portfolio in Cognex Corporation (NASDAQ:CGNX) for 268 shares. Parametric Portfolio Assocs Ltd Co stated it has 211,059 shares. Polar Cap Llp holds 0.32% of its portfolio in Cognex Corporation (NASDAQ:CGNX) for 514,072 shares. Loring Wolcott And Coolidge Fiduciary Advsrs Llp Ma reported 0% stake. Advisory Ser Net Llc stated it has 0.03% of its portfolio in Cognex Corporation (NASDAQ:CGNX). Shell Asset reported 159,452 shares. Fmr Lc accumulated 144,384 shares. Alliancebernstein Ltd Partnership holds 0.01% or 115,002 shares. Cornerstone Advisors Incorporated holds 350 shares or 0.01% of its portfolio. Teachers Retirement Sys Of The State Of Kentucky owns 0.03% invested in Cognex Corporation (NASDAQ:CGNX) for 38,740 shares. Thompson Davis Co owns 100 shares or 0.01% of their US portfolio. 5,926 were reported by Cibc Asset Mngmt. Tirschwell & Loewy holds 732,485 shares.

Since January 10, 2018, it had 1 insider purchase, and 23 selling transactions for $18.55 million activity. Shares for $228,128 were sold by Biller Scott on Monday, February 5. The insider Schenkein David P sold $1.02M. $155,305 worth of stock was sold by Bowden Christopher on Friday, February 16. Shares for $176,198 were sold by Hoerter Steven L.. Shares for $16,688 were bought by Scadden David on Friday, March 16. Foster-Cheek Kaye I sold $557,396 worth of stock or 6,800 shares.

Pdt Partners Llc, which manages about $4.99B and $3.45 billion US Long portfolio, upped its stake in Mylan N V (NASDAQ:MYL) by 184,106 shares to 562,862 shares, valued at $23.82 million in 2017Q4, according to the filing. It also increased its holding in Hub Group Inc (NASDAQ:HUBG) by 22,500 shares in the quarter, for a total of 73,900 shares, and has risen its stake in Universal Fst Prods Inc (NASDAQ:UFPI).

Among 16 analysts covering Agios Pharmaceuticals (NASDAQ:AGIO), 12 have Buy rating, 0 Sell and 4 Hold. Therefore 75% are positive. Agios Pharmaceuticals had 45 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) earned “Overweight” rating by JP Morgan on Thursday, February 15. BTIG Research initiated the shares of AGIO in report on Friday, August 19 with “Neutral” rating. As per Sunday, November 19, the company rating was maintained by SunTrust. The stock of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has “Neutral” rating given on Wednesday, March 2 by Janney Capital. On Monday, June 5 the stock rating was maintained by Canaccord Genuity with “Buy”. Oppenheimer maintained Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) rating on Sunday, June 11. Oppenheimer has “Buy” rating and $7500 target. Janney Capital downgraded Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) on Monday, June 26 to “Neutral” rating. The stock of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has “Outperform” rating given on Thursday, July 23 by Northland Capital. Needham maintained Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) rating on Friday, September 15. Needham has “Buy” rating and $72.0 target. As per Monday, December 7, the company rating was downgraded by Leerink Swann.

Analysts await Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) to report earnings on August, 14. They expect $-1.66 earnings per share, up 6.74% or $0.12 from last year’s $-1.78 per share. After $-1.63 actual earnings per share reported by Agios Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 1.84% negative EPS growth.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.01, from 1.21 in 2017Q3. It increased, as 19 investors sold AGIO shares while 48 reduced holdings. 27 funds opened positions while 55 raised stakes. 45.70 million shares or 2.27% more from 44.69 million shares in 2017Q3 were reported. Qs Llc holds 0% or 2,800 shares in its portfolio. Columbia Wanger Asset Ltd Liability Company reported 760,116 shares. Amalgamated Natl Bank holds 0.01% or 8,287 shares. International Ltd Ca holds 0.35% or 32,190 shares. Grp One Trading Lp accumulated 0.01% or 28,222 shares. 1.34 million were reported by State Street. Capital Guardian Trust owns 0.54% invested in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) for 663,089 shares. 10,078 are held by Bnp Paribas Arbitrage. Intll Inc Ca reported 27,550 shares. State Board Of Administration Of Florida Retirement Sys has 0.01% invested in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) for 54,983 shares. Citadel Limited Com reported 91,470 shares or 0% of all its holdings. Federated Investors Pa has 9,093 shares. 49,300 are owned by Canada Pension Plan Inv Board. Citigroup reported 0% in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Envestnet Asset Mngmt Inc owns 212 shares.

Cognex Corporation (NASDAQ:CGNX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *